Astellas Pharma, Inc. (TSE:4503) is looking for acquisition opportunities. Yoshihiko Hatanaka, President and Chief Executive Officer of Astellas Pharma said, "We will continue to pursue operational excellence. In addition, we will continue to proactively explore external business opportunities and acquisitions."